First Tylenol Bellwether Trial Set for June 22, 2015

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

The first Tylenol bellwether trial in multidistrict litigation (MDL) is fast approaching and lawyers from both sides are gearing up. The Pennsylvania trial involves whether the acetaminophen in various Tylenol products from Johnson & Johnson (J&J), and its subsidiary McNeill Consumer Healthcare, caused acute liver failure. U.S. District Judge Lawrence Stengel ordered jury selection on June 22, 2015 for Rana …

Study Shows Tylenol No Better Than Placebo & Hard on Your Liver

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

The New York Times reported on April 1, 2015 that Tylenol is no better than a placebo when given to patients seeking relief from spinal pain or disability. The Australian researchers, published online in The BMJ, analyzed 5, 366 patients. Acetaminophen (Tylenol) was given orally in doses between 3,000-4,000 milligrams per day. What is even more alarming is the study …

J&J Drops Plaintiff Solicitation Discovery Bid In Mesh MDL

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Johnson & Johnson has withdrawn its discovery motion to pursue its allegations that the plaintiffs’ attorneys in transvaginal mesh multidistrict litigation had engaged in illegal plaintiff solicitation and filed lawsuits without legitimate claims. U.S. District Judge Joseph Goodwin on Feb. 11 granted J&J’s motion to withdraw its discovery motion related to its claims of plaintiff solicitation, though it did not …

It’s Easy to Overdose on Tylenol, Study Warns

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

The rise in prescriptions and non-prescription use of painkillers in the U.S. is no secret – in the past decade, prescriptions for opioids have skyrocketed by 300%, making them the most prescribed drugs in the country. And the consequences of that spike can be deadly, according to the latest report from Consumer Reports: nearly 17,000 people die each year from …

J&J considering Settling Defective Hip Suit

Daniels Tredennick Pharmaceutical and Mass Torts Leave a Comment

Johnson & Johnson may pay more than $250 million to resolve suits over its ASR hip implants that were excluded from a $2.5 billion settlement of similar claims last year over the device’s failure, two people familiar with the accord said. J&J, the world’s largest seller of health-care products, is weighing whether to settle more than 1,000 lawsuits over removals …

J&J Federal Trial on Pelvic Mesh Devices Begins in West Virginia

Daniels Tredennick Pharmaceutical and Mass Torts

Johnson and Johnson (JNJ), and its subsidiary, Ethicon, Inc., are going on trial this week in the US District Court for the Southern District of West Virginia, facing charges that one of its pelvic mesh devices, the TVT-O, was defective and that the company was negligent and fraudulent in its representation of the product. We Are Mesh Survivors, a coalition …

Talcum Powder Like J&J’s Baby Powder Linked to Ovarian Cancer

Daniels Tredennick Pharmaceutical and Mass Torts

Scientists have identified a disturbing link between ovarian cancer and talcum powder and other talcum-based products, which have been promoted for feminine hygiene uses in the U.S. and across the world for decades. A study published in the medical journal Cancer Prevention Research revealed a 24 percent increased risk of ovarian tumors among women who relied on talcum-based products for …